Cargando…

Synergistic action of phages and lytic proteins with antibiotics: a combination strategy to target bacteria and biofilms

BACKGROUND: Multidrug-resistant bacteria continue to emerge owing to the abuse of antibiotics and have a considerable negative impact on people and the environment. Bacteria can easily form biofilms to improve their survival, which reduces the efficacy of antibacterial drugs. Proteins such as endoly...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Han, Li, Zong, Elbaz, Amro, Ni, Shou-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204329/
https://www.ncbi.nlm.nih.gov/pubmed/37221517
http://dx.doi.org/10.1186/s12866-023-02881-2
_version_ 1785045809164713984
author Lu, Han
Li, Zong
Elbaz, Amro
Ni, Shou-Qing
author_facet Lu, Han
Li, Zong
Elbaz, Amro
Ni, Shou-Qing
author_sort Lu, Han
collection PubMed
description BACKGROUND: Multidrug-resistant bacteria continue to emerge owing to the abuse of antibiotics and have a considerable negative impact on people and the environment. Bacteria can easily form biofilms to improve their survival, which reduces the efficacy of antibacterial drugs. Proteins such as endolysins and holins have been shown to have good antibacterial activity and effectively removal bacterial biofilms and reduce the production of drug-resistant bacteria. Recently, phages and their encoded lytic proteins have attracted attention as potential alternative antimicrobial agents. The aim of the present study was to investigate the sterilising efficacy of phages (SSE1, SGF2, and SGF3) and their encoded lytic proteins (lysozyme and holin), and to further explore their potential in combination with antibiotics. To the ultimate aim is to reduce or replace the use of antibiotics and provide more materials and options for sterilisation. RESULTS: Phages and their encoded lytic proteins were confirmed to have great advantages in sterilisation, and all exhibited significant potential for reducing bacterial resistance. Previous studies on the host spectrum demonstrated the bactericidal efficacy of three Shigella phages (SSE1, SGF2, and SGF3) and two lytic proteins (LysSSE1 and HolSSE1). In this study, we investigated the bactericidal effects on planktonic bacteria and bacterial biofilms. A combined sterilisation application of antibiotics, phages, and lytic proteins was performed. The results showed that phages and lytic proteins had better sterilisation effects than antibiotics with 1/2 minimum inhibitory concentrations (MIC) and their effect was further improved when used together with antibiotics. The best synergy was shown when combined with β- lactam antibiotics, which might be related to their mechanism of sterilising action. This approach ensures a bactericidal effect at low antibiotic concentrations. CONCLUSIONS: This study strengthens the idea that phages and lytic proteins can significantly sterilise bacteria in vitro and achieve synergistic sterilisation effects with specific antibiotics. Therefore, a suitable combination strategy may decrease the risk of drug resistance.
format Online
Article
Text
id pubmed-10204329
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102043292023-05-24 Synergistic action of phages and lytic proteins with antibiotics: a combination strategy to target bacteria and biofilms Lu, Han Li, Zong Elbaz, Amro Ni, Shou-Qing BMC Microbiol Research BACKGROUND: Multidrug-resistant bacteria continue to emerge owing to the abuse of antibiotics and have a considerable negative impact on people and the environment. Bacteria can easily form biofilms to improve their survival, which reduces the efficacy of antibacterial drugs. Proteins such as endolysins and holins have been shown to have good antibacterial activity and effectively removal bacterial biofilms and reduce the production of drug-resistant bacteria. Recently, phages and their encoded lytic proteins have attracted attention as potential alternative antimicrobial agents. The aim of the present study was to investigate the sterilising efficacy of phages (SSE1, SGF2, and SGF3) and their encoded lytic proteins (lysozyme and holin), and to further explore their potential in combination with antibiotics. To the ultimate aim is to reduce or replace the use of antibiotics and provide more materials and options for sterilisation. RESULTS: Phages and their encoded lytic proteins were confirmed to have great advantages in sterilisation, and all exhibited significant potential for reducing bacterial resistance. Previous studies on the host spectrum demonstrated the bactericidal efficacy of three Shigella phages (SSE1, SGF2, and SGF3) and two lytic proteins (LysSSE1 and HolSSE1). In this study, we investigated the bactericidal effects on planktonic bacteria and bacterial biofilms. A combined sterilisation application of antibiotics, phages, and lytic proteins was performed. The results showed that phages and lytic proteins had better sterilisation effects than antibiotics with 1/2 minimum inhibitory concentrations (MIC) and their effect was further improved when used together with antibiotics. The best synergy was shown when combined with β- lactam antibiotics, which might be related to their mechanism of sterilising action. This approach ensures a bactericidal effect at low antibiotic concentrations. CONCLUSIONS: This study strengthens the idea that phages and lytic proteins can significantly sterilise bacteria in vitro and achieve synergistic sterilisation effects with specific antibiotics. Therefore, a suitable combination strategy may decrease the risk of drug resistance. BioMed Central 2023-05-23 /pmc/articles/PMC10204329/ /pubmed/37221517 http://dx.doi.org/10.1186/s12866-023-02881-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lu, Han
Li, Zong
Elbaz, Amro
Ni, Shou-Qing
Synergistic action of phages and lytic proteins with antibiotics: a combination strategy to target bacteria and biofilms
title Synergistic action of phages and lytic proteins with antibiotics: a combination strategy to target bacteria and biofilms
title_full Synergistic action of phages and lytic proteins with antibiotics: a combination strategy to target bacteria and biofilms
title_fullStr Synergistic action of phages and lytic proteins with antibiotics: a combination strategy to target bacteria and biofilms
title_full_unstemmed Synergistic action of phages and lytic proteins with antibiotics: a combination strategy to target bacteria and biofilms
title_short Synergistic action of phages and lytic proteins with antibiotics: a combination strategy to target bacteria and biofilms
title_sort synergistic action of phages and lytic proteins with antibiotics: a combination strategy to target bacteria and biofilms
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204329/
https://www.ncbi.nlm.nih.gov/pubmed/37221517
http://dx.doi.org/10.1186/s12866-023-02881-2
work_keys_str_mv AT luhan synergisticactionofphagesandlyticproteinswithantibioticsacombinationstrategytotargetbacteriaandbiofilms
AT lizong synergisticactionofphagesandlyticproteinswithantibioticsacombinationstrategytotargetbacteriaandbiofilms
AT elbazamro synergisticactionofphagesandlyticproteinswithantibioticsacombinationstrategytotargetbacteriaandbiofilms
AT nishouqing synergisticactionofphagesandlyticproteinswithantibioticsacombinationstrategytotargetbacteriaandbiofilms